EUVIMEDEUVIMED entdecken
Crossref

Melatonin improves cholestatic liver disease via the gut‐liver axis

Xianjiao Liu, Jinyan Li, Mengdie Shi, Jun Fu, Yubo Wang, Weili Kang, Jinyan Liu, Fenxia Zhu, Kehe Huang, Xingxiang Chen, Yunhuan Liu

Journal of Pineal Research · 2024

DOI: 10.1111/jpi.12929 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pineal Research, 2024. Verfasst von Xianjiao Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Melatonin, Cholestasis, Liver Diseases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cholestatic liver disease is characterized by disturbances in the intestinal microbiota and excessive accumulation of toxic bile acids (BA) in the liver. Melatonin (MT) can improve liver diseases. However, the underlying mechanism remains unclear. This study aimed to explore the mechanism of MT on hepatic BA synthesis, liver injury, and fibrosis in 3,5‐diethoxycarbonyl‐1,4‐dihydrocollidine (DDC)‐fed and Mdr2 –/– mice. MT significantly improved hepatic injury and fibrosis with a significant decrease in hepatic BA accumulation in DDC‐fed and Mdr2 –/– mice. MT reprogramed gut microbiota and augmented fecal bile salt hydrolase activity, which was related to increasing intestinal BA deconjugation and fecal BA excretion in both DDC‐fed and Mdr2 –/– mice. MT significantly activated the intestinal farnesoid X receptor (FXR)/fibroblast growth factor 15 (FGF‐15) axis and subsequently inhibited hepatic BA synthesis in DDC‐fed and Mdr2 –/– mice. MT failed to improve DDC‐induced liver fibrosis and BA synthesis in antibiotic‐treated mice. Furthermore, MT provided protection against DDC‐induced liver injury and fibrosis in fecal microbiota transplantation mice. MT did not decrease liver injury and fibrosis in DDC‐fed intestinal epithelial cell‐specific FXR knockout mice, suggesting that the intestinal FXR mediated the anti‐fibrosis effect of MT. In conclusion, MT ameliorates cholestatic liver diseases by remodeling gut microbiota and activating intestinal FXR/FGF‐15 axis‐mediated inhibition of hepatic BA synthesis and promotion of BA excretion in mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninCholestasisLiver DiseasesMiceAnimalsLiverBile Acids and SaltsMice, KnockoutLiver CirrhosisMice, Inbred C57BL

Stichwörter der Autor:innen

bile acidcholestatic liver diseasesfarnesoid X receptorgut microbiotamelatonin

Substanzen

MelatoninBile Acids and Salts

Autor:innen und Institutionen

  • College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu, China.
  • Institute of Animal Nutritional Health, Nanjing Agricultural University, Nanjing, Jiangsu, China.
  • MOE Joint International Research, Nanjing Agricultural University, Nanjing, Jiangsu, China.
  • Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • Key Laboratory of New Drug Delivery Systems of Chinese Materia Medica, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, Jiangsu, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Liu, X., Li, J., Shi, M., Fu, J., Wang, Y., Kang, W., Liu, J., Zhu, F., Huang, K., Chen, X., & Liu, Y. (2024). Melatonin improves cholestatic liver disease via the gut‐liver axis. Journal of Pineal Research. https://doi.org/10.1111/jpi.12929

Vancouver

Liu X, Li J, Shi M, Fu J, Wang Y, Kang W, et al. Melatonin improves cholestatic liver disease via the gut‐liver axis. Journal of Pineal Research. 2024. doi:10.1111/jpi.12929

BibTeX
@article{Liu2024,
  author = {Liu, Xianjiao and Li, Jinyan and Shi, Mengdie and Fu, Jun and Wang, Yubo and Kang, Weili and Liu, Jinyan and Zhu, Fenxia and Huang, Kehe and Chen, Xingxiang and Liu, Yunhuan},
  title = {Melatonin improves cholestatic liver disease via the gut‐liver axis},
  journal = {Journal of Pineal Research},
  year = {2024},
  doi = {10.1111/jpi.12929}
}
Kostenlos starten →